Stockreport

Esperion's Multiple Positives, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Summary Esperion has bempedoic acid PDUFA up ahead. Merck's Ebola medicine receives African approval. AstraZeneca slips on estimates miss. Esperion Therapeutics Anticipa [Read more]